Spironolactone discontinuation in patients with heart failure: complex interactions with loop diuretics. Letter regarding the article 'Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT'

被引：2
|
作者：
Culic, Viktor [1 ,2 ]
Velat, Ivan [3 ]
机构：
[1] Univ Hosp Ctr Split, Dept Cardiol & Angiol, Split, Croatia
[2] Univ Split, Sch Med, Split, Croatia
[3] Univ Hosp Ctr Split, Dept Urol, Split, Croatia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷 / 01期
关键词：
FUROSEMIDE;
D O I：
10.1002/ejhf.2031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：198 / 199
页数：2
相关论文
共 50 条
  • [1] Spironolactone dose in heart failure with preserved ejection fraction: findings fromTOPCAT
    Ferreira, Joao Pedro
    Rossello, Xavier
    Pocock, Stuart J.
    Rossignol, Patrick
    Claggett, Brian L.
    Rouleau, Jean-Lucien
    Solomon, Scott D.
    Pitt, Bertram
    Pfeffer, Marc A.
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (09) : 1615 - 1624
  • [2] Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study
    Zhou, Hui-min
    Zhan, Rong-jian
    Chen, Xuanyu
    Lin, Yi-fen
    Zhang, Shao-zhao
    Zheng, Huigan
    Wang, Xueqin
    Huang, Meng-ting
    Xu, Chao-guang
    Liao, Xin-xue
    Tian, Ting
    Zhuang, Xiao-dong
    ESC HEART FAILURE, 2023, 10 (01): : 322 - 333
  • [3] Spironolactone in patients with heart failure and preserved ejection fraction
    Sanchez-Sanchez, C.
    Mendoza-Ruiz de Zuazu, H. F.
    Formiga, F.
    Manzano, L.
    Ceresuela, L. M.
    Carrera-Izquierdo, M.
    Gonzalez Franco, A.
    Epelde-Gonzalo, F.
    Cerqueiro-Gonzalez, J. M.
    Montero-Perez-Barquero, M.
    REVISTA CLINICA ESPANOLA, 2015, 215 (06): : 301 - 307
  • [4] Spironolactone in patients with heart failure and preserved ejection fraction
    Nunez, J.
    Nunez, E.
    Sanchis, J.
    REVISTA CLINICA ESPANOLA, 2016, 216 (02): : 111 - 111
  • [5] Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT?
    Mitter, Sumeet S.
    Shah, Sanjiv J.
    CURRENT ATHEROSCLEROSIS REPORTS, 2015, 17 (11)
  • [6] Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT?
    Sumeet S. Mitter
    Sanjiv J. Shah
    Current Atherosclerosis Reports, 2015, 17
  • [7] Spironolactone for Heart Failure with Preserved Ejection Fraction
    Efthimiadis, Georgios K.
    Zegkos, Thomas
    Karvounis, Haralampos
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02): : 179 - 180
  • [8] Spironolactone for Heart Failure with Preserved Ejection Fraction
    Pitt, Bertram
    Pfeffer, Marc A.
    Assmann, Susan F.
    Boineau, Robin
    Anand, Inder S.
    Claggett, Brian
    Clausell, Nadine
    Desai, Akshay S.
    Diaz, Rafael
    Fleg, Jerome L.
    Gordeev, Ivan
    Harty, Brian
    Heitner, John F.
    Kenwood, Christopher T.
    Lewis, Eldrin F.
    O'Meara, Eileen
    Probstfield, Jeffrey L.
    Shaburishvili, Tamaz
    Shah, Sanjiv J.
    Solomon, Scott D.
    Sweitzer, Nancy K.
    Yang, Song
    McKinlay, Sonja M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (15): : 1383 - 1392
  • [9] Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the spironolactone for heart failure with preserved ejection fraction (TOPCAT) trial
    De Marco, C.
    Claggett, B.
    De Denus, S.
    Huynh, T.
    Desai, A. S.
    Sirois, M. G.
    Jarolim, P.
    Solomon, S. D.
    Pitt, B.
    Rouleau, J. L.
    Pfeffer, M. A.
    O'meara, E.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3952 - 3952
  • [10] Previous heart failure hospitalization, spironolactone, and outcomes in heart failure with preserved ejection fraction - a secondary analysis of TOPCAT
    Szabo, Barna
    Benson, Lina
    Savarese, Gianluigi
    Hage, Camilla
    Fudim, Marat
    Devore, Adam
    Pitt, Bertram
    Lund, Lars H.
    AMERICAN HEART JOURNAL, 2024, 271 : 136 - 147
12345